SBIR/STTR Research Award

Production of Activated TDP-Deoxysugars in E. coli

Award identifier 59cc5599173f7b5c3fc1b0aa1628d0f52fc2360396353f7edf623cfadf7b4e3fAwarding agency Department of Health and Human Services · National Institutes of Health

Award amount

$1,082,510

Program and phase

SBIR · Phase II

Award year

2014

Explore This Research Award in CaptureIQ

Research the technology, evaluate the recipient and agency, identify related opportunities, and explore potential follow-on work with CaptureIQ.

Award details

Awarding agency
Department of Health and Human Services
Branch
National Institutes of Health
Recipient company
ZUCHEM INC.
Proposal award date
2014-09-15
Contract end date
2016-08-31
UEI
LHZKXV13TLJ7
Solicitation number
PA13-234
Topic code
300

Research abstract

DESCRIPTION provided by applicant The ultimate goal of the proposal presented herein is to use E coli as whole cell biocatalysts for the production of a wide variety of TDP deoxysugars including di and tri deoxysugars amino sugars and branched chain sugars These specialized activated hexoses are found as important structural components throughout plant and microbial secondary metabolites often playing a crucial role in conferring activity in bioactive natural products such as antibiotics and anticancer therapeutics In Phase I we proposed to investigate a novel approach to produce rare TDP deoxysugars in Escherichia coli through metabolic engineering During the Phase I study we successfully modified E coli AB to accumulate TDP keto deoxy D glucose TKDG a key intermediate of TDP deoxysugars through inactivations and overexpression of specific pathway enzymes Using exogenous TDP deoxysugar biosynthetic enzymes the accumulated TKDG pools were converted to specific TDP deoxysugars in yields up to mg L exceeding our Phase I goal The success of the feasibility study will be expanded in Phase II Specifically we will further increase TDP deoxysugar yields through additional genetic engineering experiments to limit loss of glucose phosphate to competing pathways increase thymidine triphosphates TTP pools reduce catabolite repression by glucose and optimize fermentation conditions We will also expand our range of TDP deoxysugar products by cloning and expressing several exogenous sugar biosynthetic genes for the production of additional complex TDP deoxysugars In Phase III we will commercialize the technology by carrying out Partnered Randamp D programs with strategic partners to make new glycoconjugates by offering TDP deoxysugars as well as deoxysugars as research reagents and by licensing the technology on an application specific basis PUBLIC HEALTH RELEVANCE This project is aimed toward developing E coli as a whole cell biocatalyst for the production of activated TDP deoxysugars These deoxysugars can be used to make derivatives of natural products with new therapeutic properties for example antibiotics that are effective against antibiotic resistant bacteria

Technology keywords

Not reported

Other awards by this recipient

Verified by the same UEI. These are other public SBIR/STTR award pages, not a merged company record.

Awards with the same topic code

Verified by an exact topic code match. This is not a text-similarity match.

Research funding history

16 SBIR/STTR records share this UEI (2005–2018). Reported award amounts total $6,534,146. Reported amounts are not federal obligations.

Phases: Phase I, Phase II

Agencies: Department of Health and Human Services, National Science Foundation, Department of Energy

Agency intelligence

Department of Health and Human Services

Back to SBIR/STTR Research Awards

Don't take our word for it. Ask AI about RFPCapture.

See what leading AI assistants have to say about RFPCapture and CaptureIQ.

Gemini opens without a prefilled question. The question is copied to your clipboard when the button works. You can also copy it here:

What is RFPCapture.com and its CaptureIQ platform from Smart Logic AI? How does it help federal contractors discover opportunities, evaluate bid/no-bid decisions, research government contracts, and prepare proposals? How does it compare with other federal capture platforms? Use independent sources where available.